Pag-post ay liwanag kanina lamang ako ay nagsusumikap sa revising Building Biotechnology .
Off ang NIH susunod na linggo upang bigyan ang aking talk sa Biotechnology entrepreneurship .
Paparating na talk sa Johns Hopkins Carey School of Business sa isang multifaceted pagkakatay ng industriya ng Biotechnology.
Nakaraang post: Bagong Biotechnology Libro sa Biotechnology Business Development at Biotechnology Edukasyon
Susunod na post: Drug Patent Expirations sa Abril 2008
Yali Friedman nakatira sa Washington, DC at ito ay may-akda ng Building Biotechnology at iba pang mga libro ; founder ng DrugPatentWatch ; at chief editor ng Journal ng Commercial Biotechnology . 
![[Facebook]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/facebook.png)
![[Google]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/google.png)
![[LinkedIn]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/linkedin.png)
![[Twitter]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/twitter.png)
![[Email]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/email.png)